Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Andrew Willeford
Bronchiectasis is a chronic and often progressive lung condition characterized by the permanent dilation and damage of the bronchial airways. This abstract provides a concise overview of bronchiectasis, exploring its causes, symptoms, and management strategies. Bronchiectasis can result from various factors, including infections, congenital conditions, and immune system disorders. Common symptoms include chronic cough, excessive mucus production, recurrent respiratory infections, and breathlessness. Effective management aims to alleviate symptoms, prevent further lung damage, and improve the patient's quality of life. Treatment options typically involve airway clearance techniques, antibiotic therapy, bronchodilators, and, in severe cases, surgical interventions. Comprehensive understanding of bronchiectasis is crucial for healthcare providers and patients to ensure early diagnosis and personalized care, ultimately enhancing the prognosis and overall well-being of those affected by this condition.